Louis S. Matza
Center for Health Outcomes Research
United BioSource Corporation
Bethesda
MD 20814
USA
Name/email consistency: high
- Derivation and validation of the ASK-12 adherence barrier survey. Matza, L.S., Park, J., Coyne, K.S., Skinner, E.P., Malley, K.G., Wolever, R.Q. Ann. Pharmacother (2009)
- Further testing of the reliability and validity of the ASK-20 adherence barrier questionnaire in a medical center outpatient population . Matza, L.S., Yu-Isenberg, K.S., Coyne, K.S., Park, J., Wakefield, J., Skinner, E.P., Wolever, R.Q. Curr. Med. Res. Opin (2008)
- The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy. Matza, L.S., Rousculp, M.D., Malley, K., Boye, K.S., Oglesby, A. Health. Qual. Life. Outcomes (2008)
- Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL). Matza, L.S., Johnston, J.A., Faries, D.E., Malley, K.G., Brod, M. Qual. Life. Res (2007)
- Obese versus non-obese patients with type 2 diabetes: patient-reported outcomes and utility of weight change. Matza, L.S., Yurgin, N., Boye, K.S., Malley, K., Shorr, J.M. Curr. Med. Res. Opin (2007)
- Utilities and disutilities for type 2 diabetes treatment-related attributes. Matza, L.S., Boye, K.S., Yurgin, N., Brewster-Jordan, J., Mannix, S., Shorr, J.M., Barber, B.L. Qual. Life. Res (2007)
- Validation of two generic patient-reported outcome measures in patients with type 2 diabetes. Matza, L.S., Boye, K.S., Yurgin, N. Health. Qual. Life. Outcomes (2007)
- Impact of atomoxetine on health-related quality of life and functional status in patients with ADHD. Matza, L.S., Stoeckl, M.N., Shorr, J.M., Johnston, J.A. Expert. Rev. Pharmacoecon. Outcomes. Res (2006)
- Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment. Matza, L.S., Buchanan, R., Purdon, S., Brewster-Jordan, J., Zhao, Y., Revicki, D.A. Schizophr. Bull (2006)
- A review of the economic burden of ADHD. Matza, L.S., Paramore, C., Prasad, M. Cost. Eff. Resour. Alloc (2005)
- Efficacy of olanzapine and ziprasidone for the treatment of schizophrenia: a systematic review. Matza, L.S., Baker, T.M., Revicki, D.A. CNS. Drugs (2005)
- Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UK. Matza, L.S., Secnik, K., Mannix, S., Sallee, F.R. Pharmacoeconomics (2005)
- Misdiagnosed patients with bipolar disorder: comorbidities, treatment patterns, and direct treatment costs. Matza, L.S., Rajagopalan, K.S., Thompson, C.L., de Lissovoy, G. J. Clin. Psychiatry (2005)